Capital Blue Cross is partnering with the Mark Cuban Cost Plus Drug Co. to make lower‑cost biosimilar alternatives to Humira and Stelara available to commercial members.

Sectors like finance, health care, and tech have higher confidence levels.

Sen. Rand Paul tried to persuade Robert F. Kennedy Jr., the secretary of the U.S. Department of Health and Human Services, to ...

Physicians warn rapid adoption is outpacing oversight, urging transparency, crisis protections and clearer rules as demand ...

The new program seeks to connect GLP-1 management with primary care and Amazon Pharmacy in one place, according to the ...

The company expects to file for regulatory approval of a label expansion for Ozempic pills in the United States and Rybelsus ...

What You Need To Know Big insurers say the new standards will apply to many services by Jan. 1, 2027. Cigna predicts it will use the standards for 70% of its reviews. UnitedHealthcare says it already ...

Entities can also become a "functional fiduciary" to the extent that they have any discretionary authority or control with ...

Gail Boudreaux, the chief executive officer of Elevance, also talked about employers' focus on cutting benefits costs in 2027. Especially in the market for plans for big, national employers, "we're ...

Brokers "provide an incredibly valuable service," but "we've got to be able to trust them," James Gelfand testified.